BIOMAT Database Logo BIOMAT Database Logo

[Clinical evaluation of adrenergic beta blocking agents in angina pectoris in a double blind trial]. 1971

E A Saad, and P R Prazeres, and P L Siqueira, and A Amarante, and S Levy, and A B Benchimol

UI MeSH Term Description Entries
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias

Related Publications

E A Saad, and P R Prazeres, and P L Siqueira, and A Amarante, and S Levy, and A B Benchimol
[Beta-blocking agents in angina pectoris. A double-blind trial].
February 1970, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
E A Saad, and P R Prazeres, and P L Siqueira, and A Amarante, and S Levy, and A B Benchimol
Practolol--a cardioselective beta adrenergic blocking agents in the treatment of angina pectoris 'a double blind trial'.
June 1975, The Journal of the Association of Physicians of India,
E A Saad, and P R Prazeres, and P L Siqueira, and A Amarante, and S Levy, and A B Benchimol
Clinical trials with beta-adrenergic blocking agents in angina pectoris.
March 1978, The Journal of the Association of Physicians of India,
E A Saad, and P R Prazeres, and P L Siqueira, and A Amarante, and S Levy, and A B Benchimol
Beta adrenergic blocking agents for exertional angina pectoris.
June 1982, Herz,
E A Saad, and P R Prazeres, and P L Siqueira, and A Amarante, and S Levy, and A B Benchimol
A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
June 1972, Indian heart journal,
E A Saad, and P R Prazeres, and P L Siqueira, and A Amarante, and S Levy, and A B Benchimol
[Beta-receptor adrenergic-blocking agents in arrhythmia and angina pectoris].
May 1966, Lakartidningen,
E A Saad, and P R Prazeres, and P L Siqueira, and A Amarante, and S Levy, and A B Benchimol
Beta-adrenergic blocking agents for the treatment of angina pectoris.
July 1969, Progress in cardiovascular diseases,
E A Saad, and P R Prazeres, and P L Siqueira, and A Amarante, and S Levy, and A B Benchimol
[Beta blockade and angina pectoris. A double-blind trial].
June 1970, Ugeskrift for laeger,
E A Saad, and P R Prazeres, and P L Siqueira, and A Amarante, and S Levy, and A B Benchimol
[Treatment of angina pectoris with cardioselective beta blocking agents. Double blind study with Eraldin (practolol)].
April 1971, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
E A Saad, and P R Prazeres, and P L Siqueira, and A Amarante, and S Levy, and A B Benchimol
Beta-adrenergic receptor blocking drugs in angina pectoris.
January 1974, Drugs,
Copied contents to your clipboard!